Skip to main content

Medication nonadherence and substance abuse in psychotic disorders: impact of depressive symptoms and social stability.

Publication ,  Journal Article
Elbogen, EB; Swanson, JW; Swartz, MS; Van Dorn, R
Published in: J Nerv Ment Dis
October 2005

Although studies have consistently shown a strong relationship between medication nonadherence and substance abuse in psychotic disorders, less is understood about the mechanisms underlying this relationship. The purpose of this study was to examine whether the relationship between substance abuse and medication nonadherence in psychosis is mediated by depressive symptoms and social stability. Participants interviewed (N = 528) were adults with schizophrenia and related disorders receiving public mental health services in four US states. Multivariate analyses showed substance abuse, depressive symptoms, and living stability each contributed to medication nonadherence; thus, the relationship between substance abuse and medication adherence in psychotic disorders did not appear to be mediated by the selected variables. Instead, a robust association between depressive symptoms and medication adherence was found, attesting to the utility of assessing for depression when evaluating adherence among people with psychosis. Living instability was common and related to medication nonadherence, too, warranting further investigation.

Duke Scholars

Published In

J Nerv Ment Dis

DOI

ISSN

0022-3018

Publication Date

October 2005

Volume

193

Issue

10

Start / End Page

673 / 679

Location

United States

Related Subject Headings

  • Treatment Refusal
  • Substance-Related Disorders
  • Social Environment
  • Social Adjustment
  • Risk Factors
  • Psychotic Disorders
  • Psychiatry
  • Patient Compliance
  • Multivariate Analysis
  • Male
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Elbogen, E. B., Swanson, J. W., Swartz, M. S., & Van Dorn, R. (2005). Medication nonadherence and substance abuse in psychotic disorders: impact of depressive symptoms and social stability. J Nerv Ment Dis, 193(10), 673–679. https://doi.org/10.1097/01.nmd.0000180742.51075.70
Elbogen, Eric B., Jeffrey W. Swanson, Marvin S. Swartz, and Richard Van Dorn. “Medication nonadherence and substance abuse in psychotic disorders: impact of depressive symptoms and social stability.J Nerv Ment Dis 193, no. 10 (October 2005): 673–79. https://doi.org/10.1097/01.nmd.0000180742.51075.70.
Elbogen EB, Swanson JW, Swartz MS, Van Dorn R. Medication nonadherence and substance abuse in psychotic disorders: impact of depressive symptoms and social stability. J Nerv Ment Dis. 2005 Oct;193(10):673–9.
Elbogen, Eric B., et al. “Medication nonadherence and substance abuse in psychotic disorders: impact of depressive symptoms and social stability.J Nerv Ment Dis, vol. 193, no. 10, Oct. 2005, pp. 673–79. Pubmed, doi:10.1097/01.nmd.0000180742.51075.70.
Elbogen EB, Swanson JW, Swartz MS, Van Dorn R. Medication nonadherence and substance abuse in psychotic disorders: impact of depressive symptoms and social stability. J Nerv Ment Dis. 2005 Oct;193(10):673–679.

Published In

J Nerv Ment Dis

DOI

ISSN

0022-3018

Publication Date

October 2005

Volume

193

Issue

10

Start / End Page

673 / 679

Location

United States

Related Subject Headings

  • Treatment Refusal
  • Substance-Related Disorders
  • Social Environment
  • Social Adjustment
  • Risk Factors
  • Psychotic Disorders
  • Psychiatry
  • Patient Compliance
  • Multivariate Analysis
  • Male